drugset / Trial / NCT05327296

Efficacy and Safety of Inhaled Isoflurane Delivered Via the Sedaconda ACD-S Compared to Intravenous Propofol for Sedation of Mechanically Ventilated Intensive Care Unit Adult Patients (INSPiRE-ICU2)

NCT05327296

Phase 3 Completed 282 enrolled Sedana Medical
RandomizedParallel-groupSingle-blindTreatment

Summary

This is a study to compare safety and efficacy of inhaled isoflurane administered via the Sedaconda ACD-S device system versus intravenous propofol for sedation of mechanically ventilated patients in the Intensive Care Unit (ICU) setting.

Timeline

Start
2022-06-30
Primary completion
2024-05-28
Completion
2024-11-14

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Isoflurane Other / unclassified Inhaled
Comparator Propofol Small molecule Intravenous

Indications

No indication recorded.